Wave Life Sciences, Inc. - Common Stock (NQ:WVE)

3.820 +0.040 (+1.06%)

Delayed Quote Updated: 11:45 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Wave Life Sciences, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 06, 2024

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

Via Benzinga

WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023 ↗

March 06, 2024

WVE stock results show that WAVE Life Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday ↗

March 06, 2024

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

Via Benzinga

Topics Stocks

WAVE Life Sciences's Earnings Outlook ↗

March 05, 2024

Via Benzinga

Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

March 06, 2024

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024

February 28, 2024

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy

February 27, 2024

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

WAVE Life Sciences's Earnings Outlook ↗

November 08, 2023

Via Benzinga

Earnings Scheduled For March 6, 2024 ↗

March 06, 2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.

Via Benzinga

$16.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying ↗

January 31, 2024

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

Sarepta Therapeutics Inc.: Why it's a rising gene therapy star

January 23, 2024

Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a leading commercial-stage biotech focused on developing precision gene therapy treatments for rare diseases.

Via MarketBeat

Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones

January 08, 2024

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy

December 15, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 07, 2023

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 07, 2023

Via Benzinga

Why Is Genetic Medicines-Focused Wave Life Sciences Stock Trading Lower Today? ↗

December 07, 2023

Wave Life Sciences Ltd (NASDAQ: WVE) has priced its previously announced underwritten public offering of 20 million shares at $5.00 per share with approximately

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 07, 2023

Via Benzinga

Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

December 07, 2023

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 07, 2023

It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

Via InvestorPlace

Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

December 07, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Sprinklr Reports Downbeat Earnings, Joins Chewy, GameStop And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

December 07, 2023

U.S. stock futures traded mixed this morning, with the Dow Jones futures falling around 70 points on Thursday. Shares of Sprinklr, Inc. (NYSE: CXM) shares fell sharply in pre-market trading following...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

December 06, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency

December 06, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference

November 22, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

November 09, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023

November 03, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

Earnings Scheduled For November 9, 2023 ↗

November 09, 2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.

Via Benzinga

Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day

September 28, 2023

From Wave Life Sciences USA, Inc.

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.